News

The story of monoclonal antibodies is a testament to the transformative power of scientific innovation combined with strategic business decisions. Monoclonal antibodies (mAbs) are lab-made proteins ...
Food allergies are becoming increasingly common in urban India, driven by changing diets and growing exposure to ...
Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.
During the COVID-19 pandemic, scientists learned that the critical path to infection started with the SARS-CoV-2 virus ...
Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow - and how blocking them could ...
Scientists tracked how human immune cells attack pig kidneys after transplant—and found a way to fight back using precision ...
As antibiotic-resistant "superbugs" make infections trickier to treat, some in the medical community are turning to ...
Two glioblastoma patients treated with Temferon have lived 3 years post-surgery; one had no progression, the other stabilized ...
When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow—and how blocking them could help the body fight back.
The study found that when adjusting for variables like age, race, and underlying health conditions, women had a 31% higher ...